TECX – tectonic therapeutic, inc. (US:NASDAQ)
Stock Stats
News
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
Form 4 Tectonic Therapeutic, For: Dec 09 Filed by: Schwabish Marc
Form 4 Tectonic Therapeutic, For: Dec 04 Filed by: REICIN ALISE
Form 4 Tectonic Therapeutic, For: Dec 03 Filed by: McNamara Peter
Form SC 13G/A Tectonic Therapeutic, Filed by: Newtyn Management, LLC
Form 10-Q Tectonic Therapeutic, For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.